PFIZER INC Interest Paid, Including Capitalized Interest, Operating and Investing Activities
PFIZER INC (PFE) reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $2.08 billion for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2012-02-28
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-12-31 was $213.00M, a 83.62% increase year-over-year.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-10-02 was $535.00M, a 23.24% decline year-over-year.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-07-03 was $650.00M, a 18.18% increase year-over-year.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-04-03 was $687.00M, a 13.26% decline year-over-year.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for fiscal 2011 was $2.08B, a 3.25% decline from fiscal 2010.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for fiscal 2010 was $2.15B, a 130.48% increase from fiscal 2009.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for fiscal 2009 was $935.00M, a 19.57% increase from fiscal 2008.
- PFIZER INC interest paid, including capitalized interest, operating and investing activities for fiscal 2008 was $782.00M, a 21.62% increase from fiscal 2007.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|
| 2011-12-31 | $213.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $748.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.40B derived: sum of 3 quarters · filed 2012-02-28 | $2.08B 10-K · filed 2012-02-28 |
| 2011-10-02 | $535.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $1.19B derived: sum of 2 quarters · filed 2011-11-10 | $1.87B 10-Q · filed 2011-11-10 | $1.99B derived: sum of 4 quarters · filed 2012-02-28 |
| 2011-07-03 | $650.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-11 | $1.34B 10-Q · filed 2011-08-11 | $1.45B derived: sum of 3 quarters · filed 2012-02-28 | $2.15B derived: sum of 4 quarters · filed 2012-02-28 |
| 2011-04-03 | $687.00M 10-Q · filed 2011-05-12 | $803.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.50B derived: sum of 3 quarters · filed 2012-02-28 | $2.05B derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-12-31 | $116.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $813.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.36B derived: sum of 3 quarters · filed 2012-02-28 | $2.15B 10-K · filed 2012-02-28 |
| 2010-10-03 | $697.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $1.25B derived: sum of 2 quarters · filed 2011-11-10 | $2.04B 10-Q · filed 2011-11-10 | $2.25B derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-07-04 | $550.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $1.34B 10-Q · filed 2011-08-11 | $1.55B derived: sum of 3 quarters · filed 2012-02-28 | $1.98B derived: sum of 4 quarters · filed 2012-02-28 |
| 2010-04-04 | $792.00M 10-Q · filed 2011-05-12 | $1.00B derived: sum of 2 quarters · filed 2012-02-28 | $1.43B derived: sum of 3 quarters · filed 2012-02-28 | $1.64B derived: sum of 4 quarters · filed 2012-02-28 |
| 2009-12-31 | $212.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $636.00M derived: sum of 2 quarters · filed 2012-02-28 | $851.00M derived: sum of 3 quarters · filed 2012-02-28 | $935.00M 10-K · filed 2012-02-28 |
| 2009-09-27 | $424.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-12 | $639.00M derived: sum of 2 quarters · filed 2010-11-12 | $723.00M 10-Q · filed 2010-11-12 | $964.00M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-06-28 | $215.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-12 | $299.00M 10-Q · filed 2010-08-12 | $540.00M derived: sum of 3 quarters · filed 2011-02-28 | $635.00M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-03-29 | $84.00M 10-Q · filed 2010-05-13 | $325.00M derived: sum of 2 quarters · filed 2011-02-28 | $420.00M derived: sum of 3 quarters · filed 2011-02-28 | |
| 2008-12-31 | $241.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $336.00M derived: sum of 2 quarters · filed 2011-02-28 | $782.00M 10-K · filed 2011-02-28 | |
| 2008-09-28 | $95.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $541.00M 10-Q · filed 2009-11-05 | ||
| 2008-06-29 | $446.00M 10-Q · filed 2009-08-06 | |||
| 2007-12-31 | $643.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |